Denver, CO, United States of America

Terry James Fry

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Terry James Fry in Cancer Immunotherapy

Introduction

Terry James Fry, based in Denver, Colorado, is a notable inventor in the field of cancer immunotherapy. With a focus on innovative therapeutic approaches, Fry has made significant strides in developing treatments that harness the body's immune system to combat cancer. His groundbreaking work has culminated in the holding of one patent that reflects his contributions to medicine.

Latest Patents

Fry's prominent patent, titled "Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy," introduces chimeric antigen receptors containing TSLPR-CD19 and TSLPR-CD22 antigen binding domains. This patent encompasses a variety of cutting-edge components, including nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions related to chimeric antigen receptors. Additionally, the patent outlines methods for treating or preventing cancer in subjects and elaborates on the techniques for generating chimeric antigen receptor T cells.

Career Highlights

Throughout his career, Terry James Fry has been associated with key organizations that have furthered his research and development endeavors. Notably, he has worked with Lentigen Technology, Inc. and the University of Colorado, where he was able to leverage his expertise to advance the field of immunotherapy.

Collaborations

Fry has collaborated with several esteemed professionals in his field, including his coworkers Dina Schneider and Boro Dropulic. These collaborations have provided a robust foundation for innovative research and have contributed to enhancing the methodologies and applications of cancer treatments.

Conclusion

Terry James Fry stands out as a pivotal figure in the field of cancer immunotherapy with his remarkable patent that has far-reaching implications for treatment strategies. His work exemplifies the intersection of scientific inquiry and practical application, paving the way for future innovations in cancer care. As research continues to evolve, Fry's contributions are likely to leave a significant impact on the landscape of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…